Biased signaling gives hormones, probes or drugs distinct functional outcomes via the same receptor. The Biased Signaling Atlas (https://BiasedSignalingAtlas.org) provides a community hub with data and tools to advance this paradigm, which may yield safer and more potent drugs.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Data availability
All data are available in the online Biased Signaling Atlas (https://BiasedSignalingAtlas.org) and GitHub (https://github.com/protwis/gpcrdb_data). Documentation is available at http://docs.biasedsignalingatlas.org.
Code availability
All open-source code can be obtained from GitHub (https://github.com/protwis/protwis) under the permissive Apache 2.0 License (https://www.apache.org/licenses/LICENSE-2.0).
References
Kohout, T. A. et al. J. Biol. Chem. 279, 23214–23222 (2004).
Gomes, I. et al. Proc. Natl Acad. Sci. USA 117, 11820–11828 (2020).
Spengler, D. et al. Nature 365, 170–175 (1993).
Hollenberg, M. D. et al. Br. J. Pharmacol. 171, 1180–1194 (2014).
Schmid, C. L., Raehal, K. M. & Bohn, L. M. Proc. Natl Acad. Sci. USA 105, 1079–1084 (2008).
Dean, T., Vilardaga, J. P., Potts, J. T. Jr & Gardella, T. J. Mol. Endocrinol. 22, 156–166 (2008).
Smith, J. S., Lefkowitz, R. J. & Rajagopal, S. Nat. Rev. Drug Discov. 17, 243–260 (2018).
Kenakin, T. & Christopoulos, A. Nat. Rev. Drug Discov. 12, 205–216 (2013).
Hauser, A. S., Attwood, M. M., Rask-Andersen, M., Schioth, H. B. & Gloriam, D. E. Nat. Rev. Drug Discov. 16, 829–842 (2017).
Foster, S. R. et al. Cell 179, 895–908 e821 (2019).
Kolb, P. et al. Br. J. Pharmacol 179, 3651–3674 (2022).
Anderson, A. et al. Proc. Natl Acad. Sci. USA 117, 14522–14531 (2020).
Avet, C. et al. Elife 11, 2020.2004.2020.052027 (2022).
Ghosh, E. et al. Cell Rep. 28, 3287–3299 e3286 (2019).
Wall, M. J. et al. Nat. Commun. 13, 4150 (2022).
Gillis, A. et al. Sci. Signal. 13, eaaz3140 (2020).
Omieczynski, C. et al. Preprint at bioRxiv https://doi.org/10.1101/742643 (2019).
UniProt, C. Nucleic Acids Res. 49, D480–D489 (2021).
Hauser, A. S. et al. Elife 11, 22 (2022).
Volkow, N. D. & Blanco, C. Mol. Psychiatry 26, 218–233 (2021).
Yang, P. et al. Circulation 135, 1160–1173 (2017).
Ochoa, D. et al. Nucleic Acids Res. 49, D1302–D1310 (2021).
Wojciechowicz, M. L. & Ma'ayan, A. Nat. Rev. Drug Discov. 19, 374 (2020).
Harding, S. D. et al. Nucleic Acids Res. 50, D1282–D1294 (2022).
Acknowledgements
This work was supported by grants from the Lundbeck Foundation (R313-2019-526) and the Novo Nordisk Foundation (NNF18OC0031226) to D.E.G. This article is based upon work from COST Action ERNEST (CA18133), supported by COST (European Cooperation in Science and Technology, www.cost.eu).
Author information
Authors and Affiliations
Contributions
Conceptualization, D.E.G.; methodology, A.J.K. and D.E.G.; data curation, A.S.H., E.G., K.H., L.D. and S.G.; validation: A.J.K., D.E.G. and K.H.; writing: original draft, D.E.G.; writing: review and editing, all authors; visualization, D.E.G.; funding acquisition, D.E.G.; software, A.J.K., A.M. and J.C.; supervision, A.J.K., A.S.H, D.E.G. and K.H.
Corresponding authors
Ethics declarations
Competing interests
D.E.G. and A.J.K. have part-time employments at Kvantify. After completing their contribution to this study, A.M. and S.G. moved to Novo Nordisk A/S. The remaining authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Caroli, J., Mamyrbekov, A., Harpsøe, K. et al. A community Biased Signaling Atlas. Nat Chem Biol 19, 531–535 (2023). https://doi.org/10.1038/s41589-023-01292-8
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41589-023-01292-8
